Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000242

EVP CLO & General Counsel sold 20,825 shares at $51.46 ($1,071,717)

  • EVP CLO & General Counsel acquired 20,825 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'NEIL PATRICK R. · EVP CLO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-26 Exercise or conversion : show line 1 in the form 10b5-1 +20,825 $47.34 $985,856 61,180 D
2023-12-26 Sale : show line 2 in the form 10b5-1 −20,825 $51.46 $1,071,717 40,355 D
Open-market sales · 20,825 sh · avg $51.46 · $1,071,717

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-26 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −20,825 $47.34 2024-01-02 20,825 0 D
Loading xslF345X05/edgardoc.xml…